|
DE2611690A1
(de)
*
|
1976-03-19 |
1977-09-22 |
Goedecke Ag |
Cyclische sulfonyloxyimide
|
|
US4876279A
(en)
*
|
1986-05-05 |
1989-10-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
US4894476A
(en)
*
|
1988-05-02 |
1990-01-16 |
Warner-Lambert Company |
Gabapentin monohydrate and a process for producing the same
|
|
US4960931A
(en)
*
|
1988-05-02 |
1990-10-02 |
Warner-Lambert Company |
Gabapentin mohohydrate and a process for producing the same
|
|
YU162789A
(en)
*
|
1988-09-01 |
1990-12-31 |
Lonza Ag |
2-aza-4-(alcoxycarbonyl) spiro/4,5/decan-3-ones
|
|
US5132451A
(en)
*
|
1989-08-25 |
1992-07-21 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
|
DE3928183A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Lactamfreie cyclische aminosaeuren
|
|
DE3928184A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
|
|
PH27359A
(en)
*
|
1989-08-25 |
1993-06-21 |
Warner Lambert Co |
Process for cyclic amino acid anticonvulsant compounds
|
|
DE3928182A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von gabapentin
|
|
US5319135A
(en)
*
|
1989-08-25 |
1994-06-07 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
|
FI905584A
(fi)
*
|
1989-11-16 |
1991-05-17 |
Lonza Ag |
Foerfarande foer framstaellning av 1-(aminometyl)cyklohexanaettikssyra.
|
|
US5157138A
(en)
*
|
1989-11-16 |
1992-10-20 |
Pfizer, Inc. |
Glutaric acid derivatives and preparation thereof
|
|
US5260467A
(en)
*
|
1989-11-16 |
1993-11-09 |
Pfizer Inc. |
Glutaric acid derivatives and preparation thereof
|
|
US5149870A
(en)
*
|
1989-11-16 |
1992-09-22 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl)cyclohexane acetic acid
|
|
US5136091A
(en)
*
|
1989-11-16 |
1992-08-04 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl) cyclohexane acetic acid
|
|
GB8925933D0
(en)
*
|
1989-11-16 |
1990-01-04 |
Pfizer Ltd |
Glutaric acid derivatives and preparation thereof
|
|
US5084479A
(en)
*
|
1990-01-02 |
1992-01-28 |
Warner-Lambert Company |
Novel methods for treating neurodegenerative diseases
|
|
US5025035A
(en)
*
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
|
US5792796A
(en)
*
|
1994-07-27 |
1998-08-11 |
Warner-Lambert Company |
Methods for treating anxiety and panic
|
|
US5510381A
(en)
*
|
1995-05-15 |
1996-04-23 |
Warner-Lambert Company |
Method of treatment of mania and bipolar disorder
|
|
PL328432A1
(en)
*
|
1996-02-07 |
1999-02-01 |
Warner Lambert Co |
Novel cyclic amino acids as pharmaceutic agents
|
|
BR9708200A
(pt)
*
|
1996-03-14 |
1999-07-27 |
Warner Lambert Co |
Aminoácidos cíclicos substituídos como agentes farmacéuticos
|
|
CZ287598A3
(cs)
*
|
1996-03-14 |
1999-02-17 |
Warner-Lambert Company |
Přemostěné cyklické aminokyseliny
|
|
KR100491282B1
(ko)
|
1996-07-24 |
2005-05-24 |
워너-램버트 캄파니 엘엘씨 |
통증 치료용 이소부틸가바 및 그의 유도체
|
|
EP0937032B1
(en)
*
|
1996-10-23 |
2007-05-09 |
Warner-Lambert Company LLC |
Substituted gamma aminobutyric acids as pharmaceutical agents
|
|
IL119890A
(en)
*
|
1996-12-24 |
2002-03-10 |
Teva Pharma |
Gabapentin form iii and preparation of gabapentin form ii
|
|
US6255526B1
(en)
|
1996-12-24 |
2001-07-03 |
Teva Pharmaceutical Industries Ltd. |
Preparation of gabapentin
|
|
HRP980342A2
(en)
*
|
1997-06-25 |
1999-02-28 |
Warner Lambert Co |
Anti-inflammatory method
|
|
US6329429B1
(en)
|
1997-06-25 |
2001-12-11 |
Warner-Lambert Company |
Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
|
|
US6194459B1
(en)
|
1997-08-19 |
2001-02-27 |
Warner-Lambert Company |
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
|
|
NZ502671A
(en)
*
|
1997-09-08 |
2003-01-31 |
Warner Lambert Co |
Combination of an analgesic with anti-epileptic properties and a NSAID
|
|
WO1999018063A2
(en)
|
1997-10-07 |
1999-04-15 |
Warner-Lambert Company |
Process for preparing a cyclic amino acid anticonvulsant compound
|
|
BR9813284B1
(pt)
*
|
1997-10-27 |
2012-08-21 |
|
aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica.
|
|
US6984659B2
(en)
*
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
CA2304974C
(en)
*
|
1997-12-16 |
2005-10-25 |
Warner-Lambert Company |
1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
|
|
CN1210268C
(zh)
|
1997-12-16 |
2005-07-13 |
沃尼尔·朗伯公司 |
((环)烷基取代的)－γ－氨基丁酸衍生物(=GABA类似物),其制备和在治疗神经病中的用途
|
|
US6545022B1
(en)
|
1997-12-16 |
2003-04-08 |
Pfizer Inc. |
4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
|
|
AU2463099A
(en)
*
|
1998-01-23 |
1999-08-09 |
Warner-Lambert Company |
Gabapentin and its derivatives for the treatment of muscular and skeletal pain
|
|
EP0974351A3
(en)
*
|
1998-04-24 |
2000-12-13 |
Jouveinal |
Medicament for preventing and treating gastrointestinal damage
|
|
ID26395A
(id)
*
|
1998-05-15 |
2000-12-21 |
Warner Lambert Comapny |
Turunan asam gamma-aminobutirat yang mengandung komposisi padat dan proses pembuatannya
|
|
EP1077692B1
(en)
|
1998-05-15 |
2004-07-28 |
Warner-Lambert Company LLC |
Amino acid stabilized gabapentin and pregabalin preparations and process for preparing the same
|
|
ES2137137B1
(es)
*
|
1998-05-25 |
2000-08-16 |
Medichem Sa |
Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
|
|
CA2322558C
(en)
|
1998-05-26 |
2006-04-11 |
Warner-Lambert Company |
Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
|
|
ITMI981535A1
(it)
*
|
1998-07-03 |
2000-01-03 |
Zambon Spa |
Processo per la preparazione di gabapentina
|
|
US20030045500A1
(en)
*
|
1998-07-09 |
2003-03-06 |
Leslie Magnus |
Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
|
|
FR2781793B1
(fr)
|
1998-08-03 |
2001-07-20 |
Prographarm Lab |
Procede de fabrication de granules de gabapentine enrobes
|
|
HU225502B1
(en)
*
|
1998-12-29 |
2007-01-29 |
Richter Gedeon Vegyeszet |
Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates
|
|
IT1311984B1
(it)
|
1999-03-26 |
2002-03-22 |
Bioindustria Lab Italiano Medi |
Procedimento per la preparzione di gabapentin.
|
|
EP1169060B1
(en)
*
|
1999-04-09 |
2005-08-31 |
Euro-Celtique S.A. |
Sodium channel blocker compositions and the use thereof
|
|
BR0011039A
(pt)
*
|
1999-05-28 |
2002-02-26 |
Warner Lambert Co |
Análogos de gaba substituìdos com 3-heteroarilalquila
|
|
US6710190B1
(en)
|
1999-05-28 |
2004-03-23 |
Warner-Lambert Company |
3-heteroarylalkyl substituted gaba analogs
|
|
MXPA01012319A
(es)
*
|
1999-06-10 |
2002-07-22 |
Warner Lambert Co |
Acidos 3-propil gama aminobutiricos mono y disubstituidos.
|
|
US7164034B2
(en)
*
|
1999-06-10 |
2007-01-16 |
Pfizer Inc. |
Alpha2delta ligands for fibromyalgia and other disorders
|
|
US20080207755A1
(en)
*
|
2000-05-31 |
2008-08-28 |
Pfizer Inc |
Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders
|
|
US6294198B1
(en)
|
1999-08-24 |
2001-09-25 |
Purepac Pharmaceutical Co. |
Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
|
|
HN2000000224A
(es)
*
|
1999-10-20 |
2001-04-11 |
Warner Lambert Co |
Aminoacidos biciclicos como agentes farmaceuticos
|
|
GB2362646A
(en)
*
|
2000-05-26 |
2001-11-28 |
Warner Lambert Co |
Cyclic amino acid derivatives useful as pharmaceutical agents
|
|
EP1384473A1
(en)
*
|
2000-06-16 |
2004-01-28 |
Teva Pharmaceutical Industries Ltd. |
Stable gabapentin containing more than 20 ppm of chlorine ion
|
|
AU2001266992B8
(en)
*
|
2000-06-16 |
2005-12-01 |
Teva Pharmaceutical Industries Ltd. |
Stable gabapentin having pH within a controlled range
|
|
WO2001097612A1
(en)
|
2000-06-16 |
2001-12-27 |
Teva Pharmaceutical Industries Ltd. |
Stable gabapentin containing more than 2o ppm of chlorine ion
|
|
ATE390133T1
(de)
*
|
2000-06-26 |
2008-04-15 |
Warner Lambert Co |
Gabapentinanaloga für schlafstörungen
|
|
GB2364049A
(en)
*
|
2000-06-28 |
2002-01-16 |
Warner Lambert Co |
Cyclic ketones and their use in the synthesis of amino acids
|
|
DK1317426T3
(da)
*
|
2000-09-14 |
2006-01-09 |
Gruenenthal Gmbh |
Betal-thio-aminosyrer
|
|
AU2002211863A1
(en)
*
|
2000-10-06 |
2002-04-15 |
Xenoport, Inc. |
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
|
|
US6900192B2
(en)
*
|
2000-10-06 |
2005-05-31 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
|
US6620829B2
(en)
*
|
2000-10-17 |
2003-09-16 |
Warner-Lambert Company |
Method of treating noninflammatory cartilage damage
|
|
IT1319234B1
(it)
*
|
2000-10-23 |
2003-09-26 |
Zambon Spa |
Processo di preparazione di gabapentina.
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
KR20030048105A
(ko)
|
2000-11-02 |
2003-06-18 |
테바 파마슈티컬 인더스트리즈 리미티드 |
가바펜틴 중간체의 개선된 제조 방법
|
|
PL365378A1
(en)
*
|
2000-11-30 |
2005-01-10 |
Pfizer Products Inc. |
Combination of gaba agonists and aldose reductase inhibitors
|
|
PT1337271E
(pt)
*
|
2000-11-30 |
2005-01-31 |
Pfizer Prod Inc |
Combinacao de agonistas de gaba e inibidores de sorbitol desidrogenase
|
|
IT1319674B1
(it)
*
|
2000-12-01 |
2003-10-23 |
Erregierre Spa |
Processo per la preparazione dell'acido1-(aminometil)cicloesanacetico.
|
|
US20040063994A1
(en)
*
|
2001-03-16 |
2004-04-01 |
Paolo Rossi |
Process for the preparation of cyclic amino acids
|
|
ITMI20011132A1
(it)
|
2001-05-29 |
2002-11-29 |
Procos Spa |
Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico
|
|
AU2002345664C1
(en)
*
|
2001-06-11 |
2008-03-06 |
Xenoport, Inc. |
Prodrugs of gaba analogs, compositions and uses thereof
|
|
US7232924B2
(en)
*
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
US8048917B2
(en)
*
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7186855B2
(en)
*
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US6818787B2
(en)
*
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
EP1412324A4
(en)
*
|
2001-06-11 |
2004-09-29 |
Xenoport Inc |
AMINO ACID CONJUGATES THAT RESULT IN GABA ANALOGA LASTING SYSTEMIC CONCENTRATIONS
|
|
IL144066A0
(en)
*
|
2001-06-28 |
2002-04-21 |
Bromine Compounds Ltd |
Process for the preparation of 1,1-cyclohexane diacetic monoamide
|
|
ITMI20011772A1
(it)
|
2001-08-10 |
2003-02-10 |
A M S A Anonima Materie Sint E |
Processo per la preparazione della 2,5-bis-(2,2,2-trifluoroetossi)-n-(2-piperidilmetil)-benzamide(flecainide)
|
|
PT1423168E
(pt)
*
|
2001-09-03 |
2006-05-31 |
Newron Pharm Spa |
Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
|
|
US6800782B2
(en)
*
|
2001-10-09 |
2004-10-05 |
Warner-Lambert Co. |
Anhydrous crystalline forms of gabapentin
|
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US20070184104A1
(en)
*
|
2001-10-25 |
2007-08-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
|
US20060159743A1
(en)
*
|
2001-10-25 |
2006-07-20 |
Depomed, Inc. |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US20030119908A1
(en)
*
|
2001-12-21 |
2003-06-26 |
Zambon Group S.P.A. |
Stable gabapentin compositions
|
|
ITMI20012750A1
(it)
|
2001-12-21 |
2003-06-21 |
Procos Spa |
Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
|
|
IL162028A0
(en)
*
|
2002-01-31 |
2005-11-20 |
Warner Lambert Co |
Alpha 2 delta ligands to treat tinnitus
|
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
AU2002316231A1
(en)
*
|
2002-02-19 |
2003-09-29 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
AU2003222033A1
(en)
*
|
2002-03-20 |
2003-10-08 |
Xenoport |
Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
|
|
US20040034248A1
(en)
*
|
2002-04-16 |
2004-02-19 |
Taro Pharmaceutical Industries, Ltd. |
Process for preparing gabapentin
|
|
WO2003094842A2
(en)
*
|
2002-05-07 |
2003-11-20 |
A & D Bioscience, Inc. |
Conjugates comprising central nervous system active drug
|
|
US7183259B2
(en)
*
|
2002-05-17 |
2007-02-27 |
Xenoport |
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
|
|
WO2004002462A2
(en)
*
|
2002-06-27 |
2004-01-08 |
Warner-Lambert Company Llc |
Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
|
|
CA2395931A1
(en)
*
|
2002-08-07 |
2004-02-07 |
Bernard Charles Sherman |
Solid compositions comprising gabapentin having improved stability
|
|
US7053122B2
(en)
*
|
2002-08-09 |
2006-05-30 |
Pfizer Inc |
Therapeutic use of aryl amino acid derivatives
|
|
US7419981B2
(en)
*
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
US20040092591A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Blakemore David Clive |
Therapeutic use of fused bicyclic or tricyclic amino acids
|
|
US20040092522A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Field Mark John |
Synergistic combinations
|
|
US20040092498A1
(en)
*
|
2002-08-16 |
2004-05-13 |
David Blakemore |
Substituted glycine derivatives for use as medicaments
|
|
ITMI20022071A1
(it)
*
|
2002-10-01 |
2004-04-02 |
Erregierre Spa |
Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato.
|
|
US7659305B2
(en)
*
|
2002-10-31 |
2010-02-09 |
Pfizer Inc. |
Therapeutic proline derivatives
|
|
AU2002356424A1
(en)
*
|
2002-11-18 |
2004-06-15 |
Nicholas Piramal India Limited |
Improved process for preparation of gabapentin
|
|
PT1599446E
(pt)
*
|
2002-11-20 |
2009-11-06 |
Hikal Ltd |
Um processo melhorado para a preparação de gabalactama
|
|
US20040162351A1
(en)
*
|
2002-12-11 |
2004-08-19 |
Gallop Mark A. |
Orally administered dosage forms of fused GABA analog prodrugs having reduced toxicity
|
|
WO2004052360A1
(en)
*
|
2002-12-11 |
2004-06-24 |
Xenoport, Inc. |
Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
|
|
PL377286A1
(pl)
*
|
2002-12-13 |
2006-01-23 |
Warner-Lambert Company Llc |
Analogi gabapentyny do włókniako-mięśniakowych i innych pokrewnych zaburzeń
|
|
NZ540591A
(en)
|
2002-12-13 |
2008-03-28 |
Warner Lambert Co |
Pregabalin derivatives for the treatment of fibromyalgia and other disorders
|
|
CA2451267A1
(en)
*
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
EP1572187A1
(en)
*
|
2002-12-13 |
2005-09-14 |
Warner-Lambert Company LLC |
Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
|
|
US20040180958A1
(en)
*
|
2002-12-13 |
2004-09-16 |
Taylor Charles Price |
Method of treatment
|
|
JP2006511606A
(ja)
|
2002-12-13 |
2006-04-06 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
下部尿路症状を治療するα−２−δリガンド
|
|
GB0301143D0
(en)
*
|
2003-01-17 |
2003-02-19 |
Amedis Pharm Ltd |
Compounds and their use
|
|
MXPA05007772A
(es)
*
|
2003-01-22 |
2005-09-30 |
Warner Lambert Co |
Derivados del ciclopropil (-aminoacido.
|
|
MXPA05009504A
(es)
*
|
2003-03-07 |
2005-10-18 |
Warner Lambert Co |
Derivados de (-aminoacidos sustituidos con tetrazol y oxadiazolona.
|
|
WO2004093866A1
(en)
*
|
2003-03-25 |
2004-11-04 |
Kiel Laboratories, Inc. |
Process for preparing phenolic acid salts of gabapentin
|
|
WO2004093827A2
(en)
*
|
2003-03-25 |
2004-11-04 |
Kiel Laboratories, Inc. |
Phenolic acid salts of gabapentin in solid dosage forms and methods of use
|
|
DE602004017166D1
(de)
*
|
2003-03-25 |
2008-11-27 |
Kiel Lab Inc |
Gabapentintannat in flüssigen und/oder halbfesten dosierformen
|
|
WO2004089289A2
(en)
*
|
2003-03-31 |
2004-10-21 |
Xenoport, Inc. |
Treating or preventing hot flashes using prodrugs of gaba analogs
|
|
US20040214893A1
(en)
*
|
2003-04-11 |
2004-10-28 |
Matthew Peterson |
Gabapentin compositions
|
|
ITMI20030825A1
(it)
*
|
2003-04-18 |
2004-10-19 |
Farchemia Srl |
Procedimento per la preparazione di gabapentin esente da
|
|
WO2004093780A2
(en)
*
|
2003-04-21 |
2004-11-04 |
Matrix Laboratories Ltd |
Process for the preparation of gabapentin form-ii
|
|
MXPA05012317A
(es)
*
|
2003-05-16 |
2006-01-30 |
Pfizer Prod Inc |
Combinaciones terapeuticas de agentes antipsicoticos atipicos con agentes moduladores del gaba anticonvulsivos o benzodiazepinas.
|
|
MXPA05013754A
(es)
*
|
2003-06-19 |
2006-03-08 |
Pfizer Prod Inc |
Una preparacion biocatalitica del acido 1-cianociclohexanoacetico.
|
|
US7169812B2
(en)
*
|
2003-07-01 |
2007-01-30 |
Medtronic, Inc. |
Process for producing injectable gabapentin compositions
|
|
WO2005002585A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
|
US20050013863A1
(en)
*
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
|
WO2005046566A2
(en)
*
|
2003-08-04 |
2005-05-26 |
Sun Pharmaceutical Industries Limited |
Stable gabapentin containing composition
|
|
US20050043407A1
(en)
*
|
2003-08-22 |
2005-02-24 |
Pfizer Inc |
Pharmaceutical composition for the prevention and treatment of addiction in a mammal
|
|
CA2537837A1
(en)
*
|
2003-09-11 |
2005-03-24 |
Xenoport, Inc. |
Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
|
|
AU2004271800A1
(en)
|
2003-09-12 |
2005-03-24 |
Pfizer Inc. |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
|
|
JP2007505095A
(ja)
*
|
2003-09-12 |
2007-03-08 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
うつ病及び不安障害の治療のためのアルファ−２−デルタリガンド及びｓｓｒｉ及び／又はｓｎｒｉを含む組み合わせ
|
|
WO2005027850A2
(en)
*
|
2003-09-17 |
2005-03-31 |
Xenoport, Inc. |
Treating or preventing restless legs syndrome using prodrugs of gaba analogs
|
|
JP4308263B2
(ja)
*
|
2003-10-14 |
2009-08-05 |
ゼノポート，インコーポレイティド |
γ−アミノ酪酸アナログの結晶形
|
|
ITMI20032165A1
(it)
*
|
2003-11-11 |
2005-05-12 |
Zambon Spa |
Processo di preparazione di gabapentina
|
|
EP1691811B1
(en)
|
2003-12-11 |
2014-07-23 |
Sunovion Pharmaceuticals Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
|
JP2007537151A
(ja)
*
|
2004-01-29 |
2007-12-20 |
ファイザー・プロダクツ・インク |
γ−アミノ酪酸モジュレータと５−ＨＴ１Ｂ受容体アンタゴニストとの組合せ
|
|
US20050187295A1
(en)
*
|
2004-02-19 |
2005-08-25 |
Surendra Kalyan |
Processes for the preparation of gabapentin
|
|
EP1763503A1
(en)
*
|
2004-03-17 |
2007-03-21 |
Hikal Limited |
4-t-butylgabapentin and its synthesis
|
|
ITMI20040579A1
(it)
*
|
2004-03-25 |
2004-06-25 |
Zambon Spa |
Processo di preparazione di gabapentina
|
|
EP1737473A4
(en)
*
|
2004-04-19 |
2009-08-26 |
Noven Therapeutics Llc |
COMBINATIONS OF LITHIUM AND USES THEREOF
|
|
EP1763354A2
(en)
*
|
2004-06-09 |
2007-03-21 |
Pfizer Limited |
Use of reboxetine for the treatment of pain
|
|
GB0416228D0
(en)
*
|
2004-07-20 |
2004-08-25 |
Sandoz Ind Products S A |
Process for the preparation of gabapentin
|
|
GB0419849D0
(en)
*
|
2004-09-07 |
2004-10-13 |
Pfizer Ltd |
Pharmaceutical combination
|
|
KR101277520B1
(ko)
*
|
2004-09-10 |
2013-06-21 |
뉴론 파마슈티칼즈 에스. 피. 에이. |
（할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
|
|
WO2006050514A1
(en)
|
2004-11-04 |
2006-05-11 |
Xenoport, Inc. |
Gabapentin prodrug sustained release oral dosage forms
|
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス，インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
|
UA93389C2
(en)
*
|
2005-09-23 |
2011-02-10 |
Янссен Фармацевтика H.B. |
Hexahydro cyclooctyl pyrazole cannabinoid modulators
|
|
US8378117B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
|
US8378096B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
|
BRPI0616263A2
(pt)
*
|
2005-09-23 |
2011-06-14 |
Janssen Pharmaceutica Nv |
moduladores canabinàides do tipo tetrahidro-ciclopentil pirazol
|
|
US20070123578A1
(en)
*
|
2005-09-23 |
2007-05-31 |
Fina Liotta |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
|
US7825151B2
(en)
*
|
2005-09-23 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl pyrazole cannabinoid modulators
|
|
AU2006304787A1
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
CA2625210A1
(en)
*
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
US20070117858A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Mingde Xia |
Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
|
|
US20090176882A1
(en)
*
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
|
US7526911B2
(en)
*
|
2006-02-03 |
2009-05-05 |
Rolls-Royce Corporation |
Gas turbine engine fuel system with fuel metering valve
|
|
EP1820502A1
(en)
|
2006-02-10 |
2007-08-22 |
Laboratorios Del Dr. Esteve, S.A. |
Active substance combination comprising azolylcarbinol compounds
|
|
US7795294B2
(en)
*
|
2006-02-14 |
2010-09-14 |
Janssen Pharmaceutica N.V. |
Tetrahydro-2H-indazole pyrazole cannabinoid modulators
|
|
CN101420947A
(zh)
*
|
2006-03-06 |
2009-04-29 |
辉瑞产品公司 |
用于非恢复性睡眠的α-2-δ配体
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US8012957B2
(en)
*
|
2006-03-27 |
2011-09-06 |
Janssen Pharmaceutica Nv |
Tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulators
|
|
US20070254911A1
(en)
*
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
|
US7678808B2
(en)
|
2006-05-09 |
2010-03-16 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
|
AU2007249399A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
US7442834B2
(en)
*
|
2006-06-12 |
2008-10-28 |
Zhejiang Chiral Medicine Chemicals Co., Ltd. |
Process suitable for industrial scale production of gabapentin
|
|
CN101484413B
(zh)
*
|
2006-06-30 |
2014-05-14 |
Zach系统股份公司 |
制备加巴喷丁的方法
|
|
EP2068872A1
(en)
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
CN101652133A
(zh)
*
|
2006-12-08 |
2010-02-17 |
克塞诺波特公司 |
Gaba类似物的前药用于治疗疾病的用途
|
|
RS51940B
(en)
|
2006-12-22 |
2012-02-29 |
Recordati Ireland Limited |
Combined TH2δ LIGANAD THERAPY AND NSAID FOR LOWER URINARY TRACT DISORDERS
|
|
JP2010521453A
(ja)
*
|
2007-03-15 |
2010-06-24 |
サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド |
新規プロドラッグ
|
|
WO2008157408A2
(en)
*
|
2007-06-15 |
2008-12-24 |
Xenoport, Inc. |
Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity
|
|
US7943653B2
(en)
*
|
2007-08-13 |
2011-05-17 |
Janssen Pharmaceutica N.V. |
Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
|
|
US20090062392A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched gabapentin
|
|
TW200936123A
(en)
*
|
2007-11-06 |
2009-09-01 |
Xenoport Inc |
Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain
|
|
WO2009094563A2
(en)
|
2008-01-25 |
2009-07-30 |
Xenoport, Inc. |
Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
|
|
CA2706575C
(en)
*
|
2008-01-25 |
2015-07-14 |
Xenoport, Inc. |
Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
|
|
US7868043B2
(en)
|
2008-01-25 |
2011-01-11 |
Xenoport, Inc. |
Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
|
EP2116539A1
(en)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
|
|
US20100190752A1
(en)
|
2008-09-05 |
2010-07-29 |
Gruenenthal Gmbh |
Pharmaceutical Combination
|
|
EP2344447B1
(en)
|
2008-10-08 |
2016-06-08 |
Xgene Pharmaceutical Inc |
Gaba conjugates and methods of use thereof
|
|
EP2400989B1
(en)
|
2009-02-24 |
2016-08-10 |
Nektar Therapeutics |
Gabapentin-peg conjugates
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
US20110124705A1
(en)
*
|
2009-11-24 |
2011-05-26 |
Xenoport, Inc. |
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
US20110130454A1
(en)
*
|
2009-11-24 |
2011-06-02 |
Xenoport, Inc. |
Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
JP5815552B2
(ja)
|
2009-12-08 |
2015-11-17 |
ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ |
眼疾患を治療する化合物および方法
|
|
EP2353591A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
|
|
EP2368872A1
(en)
|
2010-03-25 |
2011-09-28 |
Serichim S.r.l. |
Process for the preparation of Gabapentin
|
|
EP2388005A1
(en)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
|
|
WO2011151708A1
(en)
|
2010-06-01 |
2011-12-08 |
Rubicon Research Private Limited |
Gastroretentive dosage forms of gaba analogs
|
|
US8431739B2
(en)
|
2010-06-14 |
2013-04-30 |
Divi's Laboratories, Ltd. |
Process for the preparation of gabapentin
|
|
ES2536534T3
(es)
|
2010-07-30 |
2015-05-26 |
Toray Industries, Inc. |
Agente terapéutico o agente profiláctico para el dolor neuropático
|
|
EP2415471A1
(en)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in opioid-induced hyperalgesia
|
|
JP2013216580A
(ja)
*
|
2010-08-06 |
2013-10-24 |
Kyorin Pharmaceutical Co Ltd |
ビシクロ［２．２．２］オクチルアミン誘導体の製造方法
|
|
EP2524694A1
(en)
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in diabetes type-2 associated pain
|
|
EP2530072A1
(en)
|
2011-06-03 |
2012-12-05 |
Lacer, S.A. |
New compounds, synthesis and use thereof in the treatment of pain
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
ITMI20131757A1
(it)
|
2013-10-22 |
2015-04-23 |
Zach System Spa |
Processo di preparazione di gabapentina
|
|
EP3067430B1
(en)
|
2013-11-01 |
2020-08-12 |
Glytech, Inc. |
Method for producing d-form or l-form amino acid derivative having thiol group
|
|
JP2016540771A
(ja)
|
2013-12-17 |
2016-12-28 |
ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ |
セロトニン−ノルアドレナリン再取り込み阻害薬（ｓｎｒｉ）およびシグマ受容体リガンドの組み合わせ
|
|
EP3082790A1
(en)
|
2013-12-17 |
2016-10-26 |
Laboratorios Del. Dr. Esteve, S.A. |
Gabapentinoids and sigma receptor ligands combinations
|
|
EP2923694B1
(en)
|
2014-03-27 |
2018-11-14 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Oral liquid pharmaceutical solution of gabapentin
|
|
TWI808952B
(zh)
|
2016-12-16 |
2023-07-21 |
瑞士商愛杜西亞製藥有限公司 |
包含t型鈣通道阻斷劑之醫藥組合
|
|
EP3818981B1
(en)
|
2018-07-04 |
2024-02-21 |
Amézcua Amézcua, Federico |
Synergic pharmaceutical composition of the active enantiomer (s)-ketorolac and gabapentin for the treatment of neuropathic pain
|
|
US10399926B1
(en)
|
2018-08-01 |
2019-09-03 |
Divi's Laboratories Ltd. |
Process for the preparation of gabapentin
|
|
AU2018445164A1
(en)
|
2018-10-11 |
2021-04-22 |
Sanifit Therapeutics S.A. |
Inositol phosphates for the treatment of ectopic calcification
|
|
AU2020370758A1
(en)
|
2019-10-25 |
2022-06-02 |
Kyoto University |
Preventative or therapeutic agent for tauopathy
|
|
EP4015494A1
(en)
|
2020-12-15 |
2022-06-22 |
Sanifit Therapeutics S.A. |
Processes for the preparation of soluble salts of inositol phosphates
|
|
GB2625579A
(en)
|
2022-12-21 |
2024-06-26 |
Novumgen Ltd |
An orally disintegrating tablet containing gabapentin or pharmaceutically acceptable salts thereof and the process of preparing the same
|